0000950170-24-007941 Sample Contracts

SAB Biotherapeutics, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement
SAB Biotherapeutics, Inc. • January 26th, 2024 • Biological products, (no disgnostic substances) • New York

SAB Biotherapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

Sample 1Sample 2Sample 3See All (370)
AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.